Clinical Trials List
2021-05-31 - 2026-09-30
Phase III
Recruiting1
Terminated5
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
Trial Applicant
IQVIA RDS Taiwan Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- 廖唯昱 Division of General Internal Medicine
- 吳尚俊 Division of General Internal Medicine
- James Chih-Hsin Yang Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- Chong-Jen Yu Division of General Internal Medicine
- 許嘉林 Division of General Internal Medicine
- YEN-TING LIN Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- 錢穎群 Division of General Internal Medicine
- Jih-Hsiang Lee Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 楊景堯 Division of General Internal Medicine
- 黃俊凱 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chia-I Shen Division of Thoracic Medicine
- Chao-Hua Chiu Division of Hematology & Oncology
- 蕭慈慧 Division of Thoracic Medicine
- Chi-Lu Chiang Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
- Hsu-ching Huang Division of Thoracic Medicine
- Yuh-Min Chen Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Jui-Hung Tsai Division of Hematology & Oncology
- Wu-Chou Su Division of Hematology & Oncology
- Chun-Hui Lee Division of Hematology & Oncology
- Yu-Min Yeh Division of Hematology & Oncology
- Po-Lan Su Division of General Internal Medicine
- Shang-Yin Wu Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 王逸熙 Division of Thoracic Medicine
- 林理涵 Division of Radiology
- 黃國棟 Division of Thoracic Medicine
- Shau-Hsuan Li Division of Hematology & Oncology
- 趙東瀛 Division of Thoracic Medicine
- 李易濰 Division of Radiology
- 陳彥豪 Division of Hematology & Oncology
- 賴建豪 Division of Thoracic Medicine
- CHIN-CHOU WANG Division of Thoracic Medicine
- 林孟志 Division of Thoracic Medicine
- Chia-Cheng Tseng Division of Thoracic Medicine
- 鍾聿修 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
350 participants
